← All Carlsmed, INC filings

Carlsmed, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
CARL
Carlsmed, INC
SCHEDULE 13G: B Capital Group Discloses Significant Stake in CARLSMED
B Capital Group and its affiliated entities have reported a combined beneficial ownership of 27.8% in CARLSMED, INC.'s common stock as of September 30, 2025.
NASDAQ
CARL
Carlsmed, INC
SCHEDULE: U.S. Venture Partners Boosts Carlsmed Stake to 22%
U.S. Venture Partners and its affiliates, including managing partner Casey M. Tansey, have disclosed a combined beneficial ownership of up to 22.0% in Carlsmed, Inc. common stock.
NASDAQ
CARL
Carlsmed, INC
SCHEDULE: Michael Cordonnier Discloses 5.9% Stake in Carlsmed, Inc.
Michael Cordonnier has reported a beneficial ownership of 5.9% of Carlsmed, Inc.'s common stock following a recent reverse stock split.